Dow rises 100 points and Pfizer stock gets a 3% boost on final trial results

Wall Street stocks were edging close to record highs on Wednesday, after final results from Pfizer's COVID-19 vaccine trial showed its shot had a 95 percent success rate and two months of safety data.